Premium
Stockpiling Antiviral Drugs for the Next Influenza Pandemic
Author(s) -
Patel A,
Gorman S E
Publication year - 2009
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2009.142
Subject(s) - stockpile , pandemic , preparedness , oseltamivir , influenza pandemic , covid-19 , pandemic influenza , public health , clinical pharmacology , h1n1 pandemic , disease control , medicine , virology , pharmacology , infectious disease (medical specialty) , political science , disease , law , nursing , pathology
The threat of an influenza pandemic has been at the forefront of public health preparedness for more than 5 years. The national planning effort has included stockpiling antiviral drugs in the Centers for Disease Control and Prevention's Strategic National Stockpile (SNS). This article highlights the composition of the SNS before the 2009 H1N1 pandemic and includes considerations for future antiviral stockpile purchases, focusing on emergence of oseltamivir resistance and the need for additional pediatric supplies. Clinical Pharmacology & Therapeutics (2009); 86 3, 241–243. doi: 10.1038/clpt.2009.142